SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing significant downward pressure after reporting disappointing forward guidance and citing ongoing challenges in the Chinese market, prompting a series of analyst downgrades. Community sentiment is deeply polarized, with many investors debating whether the stock has hit a generational bottom or is caught in a long-term value trap as the brand struggles to maintain its competitive relevance against newer rivals.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is seeing heightened attention following a fiscal third-quarter earnings beat, though investor sentiment remains divided between optimism over potential cannabis policy shifts and concerns regarding the company's persistent cash burn and the performance of its beverage segment. The community is actively debating the company's long-term turnaround strategy, the impact of anticipated U.S. federal regulatory changes, and the leadership of CEO Irwin Simon.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and intense debate among investors as they grapple with a downward trend, leading many to monitor short interest data and potential technical indicators like a short squeeze. Despite current macro-economic pressures and geopolitical concerns weighing on the stock, the community remains polarized between those viewing current levels as a bargain-buy accumulation opportunity and those concerned about the company's long-term path to profitability and lack of clear communication.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is currently experiencing high volatility driven by escalating geopolitical tensions in the Middle East and concerns over oil supply disruptions in the Strait of Hormuz. The community is actively debating the stock's long-term potential amid a complex energy landscape, with sentiment split between those capitalizing on the sector's relative strength and traders attempting to navigate the risks of a potentially protracted conflict.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is trending following the announcement of a massive multi-year AI infrastructure contract, fueling intense community speculation about its low-float potential to trigger a significant short squeeze. Investors are actively debating the company's valuation shift and potential price volatility, with many comparing the stock to historical high-momentum market movers.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is experiencing significant downward pressure as investors weigh weak earnings and revenue misses against the company's aggressive but costly international expansion. Market sentiment is sharply divided, with bearish traders highlighting high debt levels and persistent housing sector headwinds, while bullish investors are betting on a potential short squeeze fueled by high short interest and speculative hopes for future tariff relief.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor ongoing project developments, including the upcoming pilot plant operations and the status of the Definitive Feasibility Study. Market participants are actively debating the stock's valuation relative to its rare earth assets while navigating volatility driven by broader sector trends and geopolitical developments.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The SPY is experiencing significant volatility driven by conflicting headlines regarding the U.S.-Iran conflict, with investors closely monitoring shifting comments on ceasefires and potential military escalations. The community is actively debating whether current market rallies represent a genuine de-escalation of tensions or a tactical trap fueled by speculative trading and political uncertainty.

Invesco QQQ Trust Series 1 - Units of beneficial interest

The Invesco QQQ Trust is experiencing extreme volatility as markets react to contradictory reports regarding a potential de-escalation of the conflict in Iran. While community sentiment remains polarized, traders are actively debating whether the rally is a genuine pivot or a bull trap driven by erratic headlines, quarter-end window dressing, and uncertainty surrounding an upcoming national address.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF (NASA) is generating significant buzz among retail traders, largely due to its 10% direct exposure to SpaceX and the broader momentum in the space exploration sector. While some community members are optimistic about its potential for growth, others are debating its transparency, low AUM, and how it compares to established, higher-volatility space plays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HC Wainwright Analysts Increase Earnings Estimates for KYTX

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for Kyverna Therapeutics in a research report issued to clients and...

Brokers Issue Forecasts for KYTX FY2027 Earnings

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Stock analysts at HC Wainwright issued their FY2027 EPS estimates for shares of Kyverna Therapeutics in a research note issued on Monday, March 30th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings per share of...

Kyverna Therapeutics (NASDAQ:KYTX) Announces Earnings Results

Kyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.80) earnings per share (EPS) for the quarter, meeting the consensus estimate of...

Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday

Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...

Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded Kyverna Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...

Wall Street Zen Downgrades Kyverna Therapeutics (NASDAQ:KYTX) to Sell

Wall Street Zen lowered Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Given Average Rating of "Moderate Buy" by Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the five analysts that are covering the stock, Marketbeat.com reports...

Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to "Hold" at Wall Street Zen

Wall Street Zen raised shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research report on Sunday...

Kyverna Therapeutics (NASDAQ:KYTX) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen cut Kyverna Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Sprott Silver Miners & Physical Silver ETF ($SLVR)

Tradr 2x Long Innovation 100 Monthly ($MQQQ)

GraniteShares Autocallable NVDA ETF ($ANV)

Direxion Daily ASML Bull 2x ($ASMU)

The ultimate tool for the active trader. This award goes to the fund that helped traders master the market—whether by protecting against risks or jumping on the latest trends to capture quick wins.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.75	--	--	N/A
Q4 '25	-$0.85	-$0.80	5.99%	BEAT
Q3 '25	-$0.97	-$0.85	12.47%	BEAT
Q2 '25	-$1.04	-$0.97	7.08%	BEAT
Q1 '25	-$1.13	-$1.03	8.50%	BEAT

KYTX
Kyverna Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest KYTX News

KYTXKyverna Therapeutics Inc.